Operating Income (Loss) in USD of VAPOTHERM INC from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
VAPOTHERM INC quarterly/annual Operating Income (Loss) history and change rate from Q1 2018 to Q2 2024.
  • VAPOTHERM INC Operating Income (Loss) for the quarter ending 30 Jun 2024 was -$9.27M, a 8.75% increase year-over-year.
  • VAPOTHERM INC Operating Income (Loss) for the twelve months ending 30 Jun 2024 was -$30.1M, a 53.2% increase year-over-year.
  • VAPOTHERM INC annual Operating Income (Loss) for 2023 was -$39.1M, a 61.1% increase from 2022.
  • VAPOTHERM INC annual Operating Income (Loss) for 2022 was -$100M, a 75.6% decline from 2021.
  • VAPOTHERM INC annual Operating Income (Loss) for 2021 was -$57.2M, a 32.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

VAPOTHERM INC Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$30.1M -$9.27M +$889K +8.75% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2024
Q1 2024 -$31M -$5.58M +$8.04M +59% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2024
Q4 2023 -$39.1M -$5.03M +$12.7M +71.6% 01 Oct 2023 31 Dec 2023 10-K 22 Feb 2024
Q3 2023 -$51.8M -$10.3M +$12.6M +55.2% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 -$64.4M -$10.2M +$29.7M +74.5% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 -$94.1M -$13.6M +$6.31M +31.7% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 -$100M -$17.7M +$277K +1.54% 01 Oct 2022 31 Dec 2022 10-K 22 Feb 2024
Q3 2022 -$101M -$22.9M -$10M -77.9% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023
Q2 2022 -$90.6M -$39.8M -$23.2M -140% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 -$67.4M -$19.9M -$10.2M -105% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023
Q4 2021 -$57.2M -$18M -$5.67M -46% 01 Oct 2021 31 Dec 2021 10-K 23 Feb 2023
Q3 2021 -$51.5M -$12.9M -$1.67M -14.9% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 -$49.8M -$16.6M -$9.83M -145% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022
Q1 2021 -$40M -$9.7M +$3.01M +23.7% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q4 2020 -$43M -$12.3M +$402K +3.16% 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2021
Q3 2020 -$43.4M -$11.2M +$427K +3.67% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021
Q2 2020 -$43.8M -$6.77M +$4.9M +42% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021
Q1 2020 -$48.7M -$12.7M -$579K -4.77% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021
Q4 2019 -$48.2M -$12.7M -$1.78M -16.3% 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2021
Q3 2019 -$46.4M -$11.6M -$2.91M -33.4% 01 Jul 2019 30 Sep 2019 10-K 24 Feb 2021
Q2 2019 -$43.5M -$11.7M -$2.52M -27.5% 01 Apr 2019 30 Jun 2019 10-K 24 Feb 2021
Q1 2019 -$41M -$12.1M -$3.72M -44.2% 01 Jan 2019 31 Mar 2019 10-K 24 Feb 2021
Q4 2018 -$37.2M -$10.9M 01 Oct 2018 31 Dec 2018 10-K 04 Mar 2020
Q3 2018 -$8.73M 01 Jul 2018 30 Sep 2018 10-K 04 Mar 2020
Q2 2018 -$9.15M 01 Apr 2018 30 Jun 2018 10-K 04 Mar 2020
Q1 2018 -$8.42M 01 Jan 2018 31 Mar 2018 10-K 04 Mar 2020

VAPOTHERM INC Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$39.1M +$61.3M +61.1% 01 Jan 2023 31 Dec 2023 10-K 22 Feb 2024
2022 -$100M -$43.2M -75.6% 01 Jan 2022 31 Dec 2022 10-K 22 Feb 2024
2021 -$57.2M -$14.2M -32.9% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2023
2020 -$43M +$5.15M +10.7% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2022
2019 -$48.2M -$10.9M -29.4% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022
2018 -$37.2M 01 Jan 2018 31 Dec 2018 10-K 04 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.